COVID-19抗原検査の世界市場レポート 2025年

COVID-19抗原検査市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.4％で、101億9,000万米ドルに成長します。予測期間の成長は、ポイントオブケア検査の拡大、新型ウイルス監視、公衆衛生対策、市場競争、新型ウイルス、継続的な脅威に起因すると考えられます。予測期間中の主な動向としては、次世代抗原検査の開発と承認、検査結果報告のためのデジタルおよびスマートフォン技術の統合、高リスク環境における検査インフラの拡大、家庭用抗原検査キットの需要増加、手頃な価格で利用しやすい検査ソリューションの重視、亜種特異的抗原検査の継続的研究などが挙げられます。

自己管理型検査キットの人気急上昇が予想されることから、COVID-19抗原検査市場の今後の成長が期待されます。自己管理型検査キットは、医療専門家や訓練を受けた担当者を必要とせず、個人が自宅で自分で使用できるように設計された診断ツールです。自己記入式検査キットの普及は、COVID-19抗原検査の普及に貢献し、ウイルスの蔓延を遅らせるとともに、個人が自宅にいながら感染を特定することを可能にします。2022年4月の米国疾病予防管理センターによると、デルタ優勢期（2021年8月～12月）からオミクロン優勢期（12月～2022年3月）にかけて、18歳以上の米国成人の間でCOVID-19の家庭内検査の利用が大幅に増加しました。COVID-19の症状がある回答者の自宅検査の利用率は5.7％から20.1％に増加しました。そのため、自己検査キットの普及がCOVID-19抗原検査市場成長の原動力となっています。

検査率の上昇が今後のCOVID-19抗原検査市場の成長を促進すると予測されます。検査率は、特定の集団内または特定の期間において実施されるCOVID-19検査などの診断検査の頻度を表します。検査率の上昇に伴い、抗原検査を含むCOVID-19検査ソリューションに対する需要が高まっています。この需要の高まりは市場の拡大に直接寄与しており、メーカーやサプライヤーはニーズの高まりに対応するため、より多くの検査を製造・販売する必要があります。2023年10月の米国立衛生研究所によると、2022年10月から2023年10月までの総COVID-19検査率は1000人当たり5.13～22,386.63人でした。したがって、検査率の増加はCOVID-19抗原検査市場の成長の主要な促進要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界COVID-19抗原検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のCOVID-19抗原検査市場：成長率分析
• 世界のCOVID-19抗原検査市場の実績：規模と成長, 2019-2024
• 世界のCOVID-19抗原検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界COVID-19抗原検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のCOVID-19抗原検査市場製品とサービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プラットフォーム
• 試薬とキット
• サービス
• 世界のCOVID-19抗原検査市場標本の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鼻咽頭スワブ
• 口腔咽頭スワブ
• 鼻腔スワブ
• 世界のCOVID-19抗原検査市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリニックと病院
• ホームケア
• 診断ラボ
• その他の用途
• 世界のCOVID-19抗原検査市場プラットフォームのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラテラルフロープラットフォーム
• ELISAプラットフォーム
• その他のプラットフォーム
• 世界のCOVID-19抗原検査市場、試薬とキットの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 検査キット
• 試薬
• 世界のCOVID-19抗原検査市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• テストサービス
• ラボサービス

第7章 地域別・国別分析

• 世界のCOVID-19抗原検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のCOVID-19抗原検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• COVID-19抗原検査市場：競合情勢
• COVID-19抗原検査市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Becton And Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation Of America Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Quidel Corporation
• SD Biosensor Inc.
• Diasorin S.P.A
• Biosynex Swiss SA
• iHealth Labs Inc.
• Everlywell Inc.
• JOYSBIO Biotechnology Co. Ltd.
• Mylab Discovery Solutions Pvt. Ltd.
• Access Bio Inc.
• RayBiotech Life Inc.
• CTK Biotech Inc.
• Artron Laboratories Inc.
• Princeton BioMeditech Corporation
• ACON Laboratories Inc.
• BioLytical Laboratories Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• COVID-19抗原検査市場2029：新たな機会を提供する国
• COVID-19抗原検査市場2029：新たな機会を提供するセグメント
• COVID-19抗原検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

COVID-19 is an infectious respiratory illness caused by the Severe Acute Respiratory Syndrome COVID-19 2 (SARS-CoV-2), affecting the human respiratory system and resulting in infections ranging from the common cold to more severe respiratory diseases. The COVID-19 antigen test serves as a diagnostic tool to identify the presence of specific proteins from the SARS-CoV-2 virus in a person's respiratory specimen. This test typically employs a sample collected from a nasal or throat swab.

The primary products and services associated with COVID-19 antigen tests include platforms, reagents and kits, and various services. Platforms refer to specific technologies or systems utilized for conducting particular tests. Nasopharyngeal swabs, oropharyngeal swabs, and nasal swab specimens are commonly used by clinics, hospitals, home care services, diagnostic labs, and other end-users in the process of conducting COVID-19 antigen tests.

The COVID-19 antigen testsCOVID-19 antigen tests market research report is one of a series of new reports from The Business Research Company that provides COVID-19 antigen testsCOVID-19 antigen tests market statistics, including COVID-19 antigen testsCOVID-19 antigen tests industry global market size, regional shares, competitors with a COVID-19 antigen testsCOVID-19 antigen tests market share, detailed COVID-19 antigen testsCOVID-19 antigen tests market segments, market trends and opportunities, and any further data you may need to thrive in the COVID-19 antigen testsCOVID-19 antigen tests industry. This COVID-19 antigen testsCOVID-19 antigen tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The COVID-19 antigen test market size has grown strongly in recent years. It will grow from $7.13 billion in 2024 to $7.65 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to pandemic outbreak, emergency regulatory approvals, supply chain challenges, government initiatives, global vaccination efforts.

The COVID-19 antigen test market size is expected to see strong growth in the next few years. It will grow to $10.19 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to point-of-care testing expansion, new variants surveillance, public health measures, market competition, emerging variants and continued threat. Major trends in the forecast period include development and approval of next-generation antigen tests, integration of digital and smartphone technologies for test result reporting, expansion of testing infrastructure in high-risk settings, increasing demand for home-based antigen test kits, emphasis on affordable and accessible testing solutions, continuous research for variants-specific antigen tests.

The anticipated surge in popularity of self-administered test kits is expected to drive the growth of the COVID-19 antigen test market in the future. Self-administered test kits are diagnostic tools designed for individuals to use on themselves at home, eliminating the need for medical professionals or trained personnel. The increased adoption of self-administered test kits contributes to the wider availability of COVID-19 antigen tests, aiding in slowing the spread of the virus and enabling individuals to identify infections in the comfort of their homes. According to the Centers for Disease Control and Prevention in April 2022, there was a significant rise in the use of at-home COVID-19 tests among U.S. adults aged 18 and older during the Delta-predominant period (August to December 2021) to the Omicron-predominant period (December to March 2022). The use of at-home tests among respondents with COVID-19-such as symptoms increased from 5.7% to 20.1%. Therefore, the increasing popularity of self-administered test kits is a driving force behind the growth of the COVID-19 antigen test market.

An upsurge in testing rates is anticipated to fuel the growth of the COVID-19 antigen test market in the future. Testing rates represent the frequency of diagnostic tests, such as COVID-19 tests, performed within a given population or over a specific period. As testing rates increase, there is a growing demand for COVID-19 testing solutions, including antigen tests. This heightened demand directly contributes to the market's expansion, requiring manufacturers and suppliers to produce and distribute more tests to meet the rising needs. According to the National Institutes of Health in October 2023, the total COVID-19 testing rate ranged from 5.13 to 22,386.63 per 1000 people from October 2022 to October 2023. Therefore, the increase in testing rates is a key driver of the COVID-19 antigen test market's growth.

In July 2022, Meridian Bioscience Inc., a U.S.-based company, announced a definitive merger agreement with SD Biosensor Inc., located in South Korea, and SJL Partners LLC, also based in Seoul, South Korea. This strategic initiative, spearheaded by a consortium including SD Biosensor and SJL, aims to enhance Meridian's ability to serve its customers as it shifts away from the peak demand for COVID-19 testing. Furthermore, this merger will facilitate the development of new diagnostic products by leveraging SD Biosensor's industry expertise and complementary offerings, thereby expanding the companies' reach and fostering innovation in the diagnostics market.

Major companies operating in the COVID-19 antigen test market report are F. Hoffmann-La Roche AG, Abbott Laboratories, Becton And Dickinson and Company, Laboratory Corporation Of America, PerkinElmer Inc., Quidel Corporation, SD Biosensor Inc., Diasorin S.P.A, Biosynex Swiss SA, iHealth Labs Inc., Everlywell Inc., JOYSBIO Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt. Ltd., Access Bio Inc., RayBiotech Life Inc., CTK Biotech Inc., Artron Laboratories Inc., Princeton BioMeditech Corporation, ACON Laboratories Inc., BioLytical Laboratories Inc., BioNote Inc., Assure Tech (Hangzhou) Co. Ltd., ADS biotech Inc., ANP Technologies Inc., BTNX Inc., Cellspect Co.Ltd., Empowered Diagnostics LLC, GenBody Inc., Beijing Wantai Biologicalpharmacy Enterprise Co. Ltd.

Asia-Pacific was the largest region in the COVID-19 antigen test market in 2024. The regions covered in the COVID-19 antigen test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the COVID-19 antigen test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The COVID-19 antigen test market consists of revenues earned by entities by providing services such as point-of-care testing (POC), telehealth services, travel testing services, and healthcare provider testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 antigen test market also includes sales of sample collection devices, extraction kits, buffers and solutions, and control materials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

COVID-19 Antigen Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on covid-19 antigen test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for covid-19 antigen test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The covid-19 antigen test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Platforms; Reagents And Kits; Services
• 2) By Specimen Type: Nasopharyngeal Swab; Oropharyngeal Swab; Nasal Swab
• 3) By End-Use: Clinics And Hospitals; Home Care; Diagnostic Labs; Other End-Uses
• Subsegments:
• 1) By Platforms: Lateral Flow Platforms; ELISA Platforms; Other Platforms
• 2) By Reagents And Kits: Test Kits; Reagents
• 3) By Services: Testing Services; Laboratory Services
• Companies Mentioned: F. Hoffmann-La Roche AG; Abbott Laboratories; Becton And Dickinson and Company; Laboratory Corporation Of America; PerkinElmer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. COVID-19 Antigen Test Market Characteristics

3. COVID-19 Antigen Test Market Trends And Strategies

4. COVID-19 Antigen Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global COVID-19 Antigen Test Growth Analysis And Strategic Analysis Framework

• 5.1. Global COVID-19 Antigen Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global COVID-19 Antigen Test Market Growth Rate Analysis
• 5.4. Global COVID-19 Antigen Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global COVID-19 Antigen Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global COVID-19 Antigen Test Total Addressable Market (TAM)

6. COVID-19 Antigen Test Market Segmentation

• 6.1. Global COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Platforms
• Reagents And Kits
• Services
• 6.2. Global COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nasopharyngeal Swab
• Oropharyngeal Swab
• Nasal Swab
• 6.3. Global COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinics And Hospitals
• Home Care
• Diagnostic Labs
• Other End-Uses
• 6.4. Global COVID-19 Antigen Test Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lateral Flow Platforms
• ELISA Platforms
• Other Platforms
• 6.5. Global COVID-19 Antigen Test Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Test Kits
• Reagents
• 6.6. Global COVID-19 Antigen Test Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Testing Services
• Laboratory Services

7. COVID-19 Antigen Test Market Regional And Country Analysis

• 7.1. Global COVID-19 Antigen Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global COVID-19 Antigen Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific COVID-19 Antigen Test Market

• 8.1. Asia-Pacific COVID-19 Antigen Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China COVID-19 Antigen Test Market

• 9.1. China COVID-19 Antigen Test Market Overview
• 9.2. China COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India COVID-19 Antigen Test Market

• 10.1. India COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan COVID-19 Antigen Test Market

• 11.1. Japan COVID-19 Antigen Test Market Overview
• 11.2. Japan COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia COVID-19 Antigen Test Market

• 12.1. Australia COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia COVID-19 Antigen Test Market

• 13.1. Indonesia COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea COVID-19 Antigen Test Market

• 14.1. South Korea COVID-19 Antigen Test Market Overview
• 14.2. South Korea COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe COVID-19 Antigen Test Market

• 15.1. Western Europe COVID-19 Antigen Test Market Overview
• 15.2. Western Europe COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK COVID-19 Antigen Test Market

• 16.1. UK COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany COVID-19 Antigen Test Market

• 17.1. Germany COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France COVID-19 Antigen Test Market

• 18.1. France COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy COVID-19 Antigen Test Market

• 19.1. Italy COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain COVID-19 Antigen Test Market

• 20.1. Spain COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe COVID-19 Antigen Test Market

• 21.1. Eastern Europe COVID-19 Antigen Test Market Overview
• 21.2. Eastern Europe COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia COVID-19 Antigen Test Market

• 22.1. Russia COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America COVID-19 Antigen Test Market

• 23.1. North America COVID-19 Antigen Test Market Overview
• 23.2. North America COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA COVID-19 Antigen Test Market

• 24.1. USA COVID-19 Antigen Test Market Overview
• 24.2. USA COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada COVID-19 Antigen Test Market

• 25.1. Canada COVID-19 Antigen Test Market Overview
• 25.2. Canada COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America COVID-19 Antigen Test Market

• 26.1. South America COVID-19 Antigen Test Market Overview
• 26.2. South America COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil COVID-19 Antigen Test Market

• 27.1. Brazil COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East COVID-19 Antigen Test Market

• 28.1. Middle East COVID-19 Antigen Test Market Overview
• 28.2. Middle East COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa COVID-19 Antigen Test Market

• 29.1. Africa COVID-19 Antigen Test Market Overview
• 29.2. Africa COVID-19 Antigen Test Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa COVID-19 Antigen Test Market, Segmentation By Specimen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa COVID-19 Antigen Test Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. COVID-19 Antigen Test Market Competitive Landscape And Company Profiles

• 30.1. COVID-19 Antigen Test Market Competitive Landscape
• 30.2. COVID-19 Antigen Test Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Becton And Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Laboratory Corporation Of America Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. COVID-19 Antigen Test Market Other Major And Innovative Companies

• 31.1. Quidel Corporation
• 31.2. SD Biosensor Inc.
• 31.3. Diasorin S.P.A
• 31.4. Biosynex Swiss SA
• 31.5. iHealth Labs Inc.
• 31.6. Everlywell Inc.
• 31.7. JOYSBIO Biotechnology Co. Ltd.
• 31.8. Mylab Discovery Solutions Pvt. Ltd.
• 31.9. Access Bio Inc.
• 31.10. RayBiotech Life Inc.
• 31.11. CTK Biotech Inc.
• 31.12. Artron Laboratories Inc.
• 31.13. Princeton BioMeditech Corporation
• 31.14. ACON Laboratories Inc.
• 31.15. BioLytical Laboratories Inc.

32. Global COVID-19 Antigen Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The COVID-19 Antigen Test Market

34. Recent Developments In The COVID-19 Antigen Test Market

35. COVID-19 Antigen Test Market High Potential Countries, Segments and Strategies

• 35.1 COVID-19 Antigen Test Market In 2029 - Countries Offering Most New Opportunities
• 35.2 COVID-19 Antigen Test Market In 2029 - Segments Offering Most New Opportunities
• 35.3 COVID-19 Antigen Test Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer